Literature DB >> 19714258

Misreporting, Missing Data, and Multiple Imputation: Improving Accuracy of Cancer Registry Databases.

Yulei He1, Recai Yucel, Alan M Zaslavsky.   

Abstract

Entities:  

Year:  2008        PMID： 19714258      PMCID： PMC2731972          DOI： 10.1007/s144-008-0030-6

Source DB:  PubMed          Journal:  Chance (N Y)        ISSN： 0933-2480


× No keyword cloud information.
  2 in total

1.  Profiling providers on use of adjuvant chemotherapy by combining cancer registry and medical record data.

Authors:  Hui Zheng; Recai Yucel; John Z Ayanian; Alan M Zaslavsky
Journal:  Med Care       Date:  2006-01       Impact factor: 2.983

2.  Use of adjuvant chemotherapy and radiation therapy for colorectal cancer in a population-based cohort.

Authors:  John Z Ayanian; Alan M Zaslavsky; Charles S Fuchs; Edward Guadagnoli; Cynthia M Creech; Rosemary D Cress; Lilia C O'Connor; Dee W West; Mark E Allen; Robert E Wolf; William E Wright
Journal:  J Clin Oncol       Date:  2003-04-01       Impact factor: 44.544
  2 in total
  7 in total

1.  Socio-demographic inequalities in stage of cancer diagnosis: evidence from patients with female breast, lung, colon, rectal, prostate, renal, bladder, melanoma, ovarian and endometrial cancer.

Authors:  G Lyratzopoulos; G A Abel; C H Brown; B A Rous; S A Vernon; M Roland; D C Greenberg
Journal:  Ann Oncol       Date:  2012-11-12       Impact factor: 32.976

2.  Gender inequalities in the promptness of diagnosis of bladder and renal cancer after symptomatic presentation: evidence from secondary analysis of an English primary care audit survey.

Authors:  Georgios Lyratzopoulos; Gary A Abel; Sean McPhail; Richard D Neal; Gregory P Rubin
Journal:  BMJ Open       Date:  2013-06-24       Impact factor: 2.692

3.  Variation in advanced stage at diagnosis of lung and female breast cancer in an English region 2006-2009.

Authors:  G Lyratzopoulos; G A Abel; J M Barbiere; C H Brown; B A Rous; D C Greenberg
Journal:  Br J Cancer       Date:  2012-03-01       Impact factor: 7.640

4.  A holistic comparative analysis of diagnostic tests for urothelial carcinoma: a study of Cxbladder Detect, UroVysion® FISH, NMP22® and cytology based on imputation of multiple datasets.

Authors:  Vivienne Breen; Nikola Kasabov; Ashish M Kamat; Elsie Jacobson; James M Suttie; Paul J O'Sullivan; Laimonis Kavalieris; David G Darling
Journal:  BMC Med Res Methodol       Date:  2015-05-12       Impact factor: 4.615

5.  Missing data and chance variation in public reporting of cancer stage at diagnosis: Cross-sectional analysis of population-based data in England.

Authors:  Matthew E Barclay; Georgios Lyratzopoulos; David C Greenberg; Gary A Abel
Journal:  Cancer Epidemiol       Date:  2017-11-23       Impact factor: 2.984

6.  Estimation of the Incidence of Hepatocellular Carcinoma and Cholangiocarcinoma in Songkhla, Thailand, 1989-2013, Using Multiple Imputation Method.

Authors:  Seesai Yeesoonsang; Surichai Bilheem; Edward McNeil; Sophon Iamsirithaworn; Chuleeporn Jiraphongsa; Hutcha Sriplung
Journal:  Cancer Res Treat       Date:  2016-05-18       Impact factor: 4.679

7.  Socio-demographic variation in stage at diagnosis of breast, bladder, colon, endometrial, lung, melanoma, prostate, rectal, renal and ovarian cancer in England and its population impact.

Authors:  M E Barclay; G A Abel; David C Greenberg; B Rous; G Lyratzopoulos
Journal:  Br J Cancer       Date:  2021-02-09       Impact factor: 7.640
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.